Allergone 8 mg kapsler, hårde Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

allergone 8 mg kapsler, hårde

orifarm generics a/s - acrivastin - kapsler, hårde - 8 mg

Benadryl 8 mg kapsler, hårde Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

benadryl 8 mg kapsler, hårde

mcneil denmark aps - acrivastin - kapsler, hårde - 8 mg

Robinul-Neostigmin 0,5 + 2,5 mg/ml injektionsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

robinul-neostigmin 0,5 + 2,5 mg/ml injektionsvæske, opløsning

viatris aps - glycopyrroniumbromid, neostigminmethylsulfat - injektionsvæske, opløsning - 0,5 + 2,5 mg/ml

Isoptin Retard 120 mg depottabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

isoptin retard 120 mg depottabletter

paranova danmark a/s - verapamilhydrochlorid - depottabletter - 120 mg

Isoptin SR 120 mg depottabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

isoptin sr 120 mg depottabletter

orifarm a/s - verapamilhydrochlorid - depottabletter - 120 mg

Tagrisso Den Europæiske Union - dansk - EMA (European Medicines Agency)

tagrisso

astrazeneca ab - osimertinib mesilate - carcinom, ikke-småcellet lunge - andre antineoplastiske midler, protein kinase hæmmere - tagrisso as monotherapy is indicated for:- the adjuvant treatment after complete tumour resection in adult patients with stage ib-iiia non-small cell lung cancer (nsclc) whose tumours have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations- the first-line treatment of adult patients nsclc with activating egfr mutations. - the treatment of adult patients with locally advanced or metastatic egfr t790m mutation-positive nsclc. tagrisso as monotherapy is indicated for:- the adjuvant treatment after complete tumour resection in adult patients with stage ib-iiia non-small cell lung cancer (nsclc) whose tumours have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations. - the first-line treatment of adult patients with locally advanced or metastatic nsclc with activating egfr mutations. - the treatment of adult patients with locally advanced or metastatic egfr t790m mutation-positive nsclc.

MERON PLUS AC Italien - dansk - Ministero della Salute

meron plus ac

Hexasoptin Retard 120 mg depotkapsler, hårde Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

hexasoptin retard 120 mg depotkapsler, hårde

sandoz a/s - verapamilhydrochlorid - depotkapsler, hårde - 120 mg

Isoptin Retard 120 mg depottabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

isoptin retard 120 mg depottabletter

viatris aps - verapamilhydrochlorid - depottabletter - 120 mg

Isoptin Retard 120 mg depottabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

isoptin retard 120 mg depottabletter

europharma.dk aps - verapamilhydrochlorid - depottabletter - 120 mg